Capha Pharmaceuticals Inc.
FPSUF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3 | $1 | $1 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $0 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $4 | $2 | $1 | $2 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4 | $2 | $2 | $2 |
| Liabilities | – | – | – | – |
| Payables | $7 | $21 | $12 | $7 |
| Short-Term Debt | $590 | $560 | $560 | $541 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $6 |
| Total Curr. Liab. | $599 | $581 | $572 | $553 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $599 | $581 | $572 | $553 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $11,454 | $11,454 | $11,454 | $8,479 |
| Retained Earnings | -$15,740 | -$15,725 | -$15,716 | -$11,619 |
| AOCI | $127 | $127 | $127 | $2,732 |
| Other Equity | $3,565 | $3,565 | $3,565 | -$143 |
| Total Equity | -$594 | -$579 | -$571 | -$551 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4 | $2 | $2 | $2 |
| Net Debt | $586 | $559 | $559 | $539 |